Plinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progression on PD-1 or PD-L1 Targeted Antibodies
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
UMC Utrecht
Peking University First Hospital
Abramson Cancer Center at Penn Medicine
Australian and New Zealand Urogenital and Prostate Cancer Trials Group
University of Erlangen-Nürnberg Medical School
Mayo Clinic
Sohag University
UNICANCER
Institute of Cancer Research, United Kingdom
Trans Tasman Radiation Oncology Group
Alliance for Clinical Trials in Oncology
Institut du Cancer de Montpellier - Val d'Aurelle
Spanish Oncology Genito-Urinary Group
University of Chicago